...
"the process of washing out an organ or wound with a continuous flow of water or medication" - the concept is the "continuous flow" rather than the "apply" or the "bathe"
Specific issues
38943003 | Gingival (intended site) |
Gingival intended site sits separately in the hierarchy from other oromucosal concepts; we think that "gingival" should be a child of oromucosal
385213000: Conventional release vapor solution for inhalation (dose form)
...
| Dose form | Comments |
|---|---|
| Prolonged-release solution for injection | Used for products like Buvidal, where it is the dose form (the formulation of the solution for injection) causes the prolonged release; the substance is (still) plain buprenorphine |
| Oral/rectal solution (and others) | Multiple intended site dose forms should be included, following the pattern that already exists for eye/ear/nose drops. BUT not all EDQM should be added - there should be evaluation (e.g. EDQM have rejected a "Solution for injection/infusion/rectal use" concept because "it is not appropriate for safety reasons, owing to the different microbiological requirements for the routes of administration covered" For the decision support use case, grouping concepts by their intended site is often very helpful (for example) If there is a multiple site manufactured dose form being used by products, the appropriate administrable dose form should be created in SNOMED CT even if there are no products using this directly….since some countries/implementations will be representing the administrable concept as well as the manufactured concept. The example for this in our list is the “Powder for intravesical solution/solution for injection” with its administrable dose form of “Intravesical solution/solution for injection” |
7738943003 7738738943003 | Gingival (intended site) |43003 | Gingival (intended site) |8943003 | Gingival (intended site) |3738943003 | Gingival (intended site) |8943003 | Gingival (intended site) |